Baker SD - Search Results

1

Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.

Smith BD, Jones RJ, Cho E, Kowalski J, Karp JE, Gore SD, Vala M, Meade B, Baker SD, Zhao M, Piantadosi S, Zhang Z, Blumenthal G, Warlick ED, Brodsky RA, Murgo A, Rudek MA, Matsui WH. Smith BD, et al. Among authors: baker sd. Leuk Res. 2011 Jan;35(1):87-94. doi: 10.1016/j.leukres.2010.06.001. Epub 2010 Jul 3. Leuk Res. 2011. PMID: 20598742 Free PMC article. Clinical Trial.

2

High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: a phase II and pharmacodynamic study.

Rowinsky EK, Baker SD, Burks K, O'Reilly S, Donehower RC, Grochow LB. Rowinsky EK, et al. Among authors: baker sd. Ann Oncol. 1998 Feb;9(2):173-80. doi: 10.1023/a:1008266630701. Ann Oncol. 1998. PMID: 9553662 Clinical Trial.

3

A phase I and pharmacological study of topotecan infused over 30 minutes for five days in patients with refractory acute leukemia.

Rowinsky EK, Kaufmann SH, Baker SD, Miller CB, Sartorius SE, Bowling MK, Chen TL, Donehower RC, Gore SD. Rowinsky EK, et al. Among authors: baker sd. Clin Cancer Res. 1996 Dec;2(12):1921-30. Clin Cancer Res. 1996. PMID: 9816150 Clinical Trial.

4

Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography-tandem mass spectrometry.

Zhao M, He P, Rudek MA, Hidalgo M, Baker SD. Zhao M, et al. Among authors: baker sd. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 15;793(2):413-20. doi: 10.1016/s1570-0232(03)00356-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12906916

5

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

Zhao M, Zabelina Y, Rudek MA, Wolff AC, Baker SD. Zhao M, et al. Among authors: baker sd. J Pharm Biomed Anal. 2003 Nov 24;33(4):725-33. doi: 10.1016/s0731-7085(03)00424-2. J Pharm Biomed Anal. 2003. PMID: 14623599

6

Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry.

Baker SD, Zhao M, He P, Carducci MA, Verweij J, Sparreboom A. Baker SD, et al. Anal Biochem. 2004 Jan 15;324(2):276-84. doi: 10.1016/j.ab.2003.09.038. Anal Biochem. 2004. PMID: 14690692

7

Temozolomide in patients with advanced cancer: phase I and pharmacokinetic study.

Rudek MA, Donehower RC, Statkevich P, Batra VK, Cutler DL, Baker SD. Rudek MA, et al. Among authors: baker sd. Pharmacotherapy. 2004 Jan;24(1):16-25. doi: 10.1592/phco.24.1.16.34800. Pharmacotherapy. 2004. PMID: 14740784 Clinical Trial.

8

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA. Baker SD, et al. Clin Cancer Res. 2004 Mar 15;10(6):1976-83. doi: 10.1158/1078-0432.ccr-0842-03. Clin Cancer Res. 2004. PMID: 15041715 Clinical Trial.

9

Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy.

Rudek MA, Sparreboom A, Garrett-Mayer ES, Armstrong DK, Wolff AC, Verweij J, Baker SD. Rudek MA, et al. Among authors: baker sd. Eur J Cancer. 2004 May;40(8):1170-8. doi: 10.1016/j.ejca.2003.12.026. Eur J Cancer. 2004. PMID: 15110880

10

A method for determination of dimethyl benzoylphenyl urea (BPU) in human plasma by using LC/UV.

Rudek MA, Zabelina Y, Zhao M, Wolff AC, Baker SD. Rudek MA, et al. Among authors: baker sd. Biomed Chromatogr. 2004 Jun;18(5):282-7. doi: 10.1002/bmc.314. Biomed Chromatogr. 2004. PMID: 15236435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters